Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia

scientific article published on 01 January 2003

Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1378/CHEST.123.1.174
P698PubMed publication ID12527619

P50authorJordi RelloQ37370747
Maria BodíQ70678722
P2093author name stringEmili Diaz
Miguel Gallego
Marta Navarro
Dolors Mariscal
Jordi Valles
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectpneumoniaQ12192
P304page(s)174-180
P577publication date2003-01-01
P1433published inChestQ5093377
P1476titleMicrobiological testing and outcome of patients with severe community-acquired pneumonia
P478volume123

Reverse relations

cites work (P2860)
Q61864376Q61864376
Q61797266A case report of community-acquired Pseudomonas aeruginosa pneumonia complicated with MODS in a previously healthy patient and related literature review
Q30399952Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection
Q39051283Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.
Q36056874Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy
Q57237831Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
Q61864365Comment évaluer, orienter et suivre un patient ayant une pneumonie aiguë communautaire ? Une exacerbation de bronchopneumopathie chronique obstructive ?
Q37696804Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.
Q51719782Community-acquired lobar pneumonia caused by Pseudomonas aeruginosa infection in Japan: a case report with histological and immunohistochemical examination.
Q33822603Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumonia
Q36688955Current clinical management of Legionnaires' disease
Q21195015Demographics, guidelines, and clinical experience in severe community-acquired pneumonia
Q37755008Diagnosis of community-acquired pneumonia in adults
Q42219508Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia.
Q35544707Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study
Q44506906Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia
Q34593229Etiology and outcome of severe community acquired pneumonia in immunocompetent adults
Q55472226Evaluation of the Quality of Care among Hospitalized Adult Patients with Community-Acquired Pneumonia in Korea.
Q28249185Guidelines for the management of adult lower respiratory tract infections--full version
Q46076297Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit
Q54977074How to manage Pseudomonas aeruginosa infections.
Q52912099Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
Q47766508Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction
Q45221743Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration
Q37153323Linking joint commission inpatient core measures and national patient safety goals with evidence
Q48002821Management of community-acquired pneumonia in persons with spinal cord injury.
Q35917265Management of respiratory infections in the elderly
Q28069467Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
Q43596478Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough.
Q36514914Optimal therapy for severe pneumococcal community-acquired pneumonia
Q58706621Physicians' utilization of microbiologic reports and determinants of their preference to order culture in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
Q41976368Pneumonia in adults: the practical emergency department perspective
Q34928386Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.
Q34683959Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.
Q38900979Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU.
Q38181699Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia
Q82556263The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit
Q38067619The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.
Q34626378Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam
Q36062027Treatment of Legionnaires' disease
Q40823340Use of Tracheal Aspirate Culture in Newly Intubated Patients with Community-Onset Pneumonia
Q37022437Validation of a prediction rule for prognosis of severe community-acquired pneumonia
Q37046209Value of RVP in clinical settings: intensive care
Q79344025[Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections]
Q79340135[Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features]
Q91910734[Which samples to obtain in the emergency department for the microbiological diagnosis of community-acquired pneumonia in the immunocompetent patient?]

Search more.